As drug discovery evolves, the complexity of new drug molecules necessitates advanced delivery technologies. Austin Px's Elizabeth Hickman and Dave Miller describe the challenges posed by poorly soluble drugs in contemporary pipelines, stemming from methods like AI and structure-based design. With conventional drug delivery methods insufficient for complex compounds, innovative solutions like KinetiSol emerge, enabling absorption without organic solvents or significant thermal degradation. This advancement is crucial, especially for oncology treatments targeting previously unreachable pathways.
1. Drug complexity increases with advanced discovery methods. 2. Poor solubility in drug pipelines is a rising concern. 3. Conventional delivery systems struggle with modern drug characteristics. 4. KinetiSol technology offers a new approach to drug absorption. 5. The shift from nature to lab-based compound libraries enhances drug target exploration. 6. Innovations are crucial for treating chronic diseases like cancer. 7. AI and structure-based designs open new potential compounds.
Listen Tab content
